Evaluation of Efficacy and Safety of VPM1002 in Comparison to BCG in Prevention of Tb Infection in Infants

NCT04351685 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6940

Enrollment

INDUSTRY

Sponsor class

Conditions

Mycobacterium Tuberculosis Infection

Interventions

BIOLOGICAL: VPM1002
BIOLOGICAL: BCG SII

Sponsor

Serum Institute of India Pvt. Ltd.

Collaborators

[object Object]